Cipla Pharmaceuticals is a global company which was founded in 1935 by Dr. K.A Hamied and its main mission is to provide medical support to every patient.
It is one of the biggest pharmaceutical and biotechnology companies in India today and has presence in around 170 countries including Europe, South Africa and North America. APIs, Veterinary and Formulation are its highlighted products and services.
It is headquartered in Mumbai in the state of Maharashtra. Cipla mainly develops medicines to treat diseases of arthritis, weight control, depression and cardiovascular diseases. Cipla is the world’s largest antiretroviral drugs developer and sells APIs as well as personal care products to other manufacturers. Cipla has well-defined portfolio and innovative Research and Development facilities for developing innovative systems for drug delivery both for existing and new drugs as well as its major focus is on developing new medical devices. Cipla spends heavily on research and development and this financial year it spend around 940 crores.
Cipla has a very well- spread distribution network and a strong presence in the retail prescription market in India. Company always put quality on the fore-front and adheres to all the regulatory standards.
Cipla has 34 manufacturing facilities in India which is spread across eight cities and are approved by major regulatory authorities.
Cipla has also received many awards and accolades for its innovation and excellence and mainly does strategic alliances for the development and distribution of their products.